201 RESULTS
RESEARCH NEWS 2019-10-03 Research News A drug being tested for its ability to calm agitation in Alzheimer’s disease provided no benefit in the TRIAD- 2 Phase 3 trial, according to topline results announced by Avanir Pharmaceuticals on September 27 (see press release). The drug,
COMMUNITY NEWS 2019-10-02 Community News Modules. Clusters. Networks. eQTLs. Big data has exposed a plethora of biological pathways and potential drug targets for AD in recent years, but how to use all this information? A new initiative aims to leverage growing reams of data into
RESEARCH NEWS 2019-09-28 Research News In a small percentage of people with Alzheimer’s disease, behavioral changes early on—such as a disregard for social norms or loss of empathy—can lead physicians to mistakenly diagnose behavioral variant frontotemporal dementia (bvFTD). How
RESEARCH NEWS 2019-09-27 Research News Regular exercise infuses the blood with factors that benefit the brain, according to a manuscript posted on the bioRχiv preprint server on September 19. Researchers led by Tony Wyss-Coray of Stanford University reported that plasma taken fro
RESEARCH NEWS 2019-09-27 Research News The LRRK2 variant, G2019S, increases a person’s chances of getting Parkinson’s disease, but may help protect against infection, according to research in the September 25 Science Translational Medicine. Scientists led by Michael Schlossmacher
RESEARCH NEWS 2019-09-24 Research News Mitochondrial fragments, jettisoned by stressed cells, create trouble for other cells, according to a study in the September 23 Nature Neuroscience. Researchers led by Daria Mochly-Rosen at Stanford University School of Medicine report that
